A new study in mice found that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission. This approach shows such promise that it's already being tested in an ongoing clinical trial in people with advanced bladder…
Read More
ctDNA Identifies Patients Who Benefit From Immunotherapy in MIUC
Among patients with muscle-invasive urothelial carcinoma (MIUC), the presence of detectable circulating tumor DNA (ctDNA) after surgery may identify those who are likely to benefit from adjuvant immunotherapy with the immune checkpoint inhibitor atezolizumab (Tecentriq). The finding comes from a…
Read More
Vexazone
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VEXAZONE contains the active ingredient pioglitazone hydrochloride CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Vexazone. It does not contain…
Read More